AllNewsPhotosVideos
Cadila Healthcare

Zydus Cadila

Zydus cadila, Latest News

Cadila Healthcare Ltd is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India. The company is one of the leading pharmaceutical companies in India, with INR 119.05 Billion revenue.
Read More
Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases - Hindi News | Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases | Latest national News at Lokmattimes.com

National :Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. ...

Study finds Moderna's COVID-19 vaccine 90 pc effective six months after second dose - Hindi News | Study finds Moderna's COVID-19 vaccine 90 pc effective six months after second dose | Latest international News at Lokmattimes.com

International :Study finds Moderna's COVID-19 vaccine 90 pc effective six months after second dose

Moderna announced on Tuesday (local time) that their coronavirus vaccine was 90 per cent effective six months after a person receives their second dose. ...

TVS Motor Company sales in March 2021 grow by 123 per cent - Hindi News | TVS Motor Company sales in March 2021 grow by 123 per cent | Latest business News at Lokmattimes.com

Business :TVS Motor Company sales in March 2021 grow by 123 per cent

TVS Motor Company registered sales of 322,683 units in March 2021 as against 144,739 units in March 2020. ...

EdTech startup Mokusei intelligence seeks partners, collaborators, and reviewers for its upcoming Pilot Program - Hindi News | EdTech startup Mokusei intelligence seeks partners, collaborators, and reviewers for its upcoming Pilot Program | Latest business News at Lokmattimes.com

Business :EdTech startup Mokusei intelligence seeks partners, collaborators, and reviewers for its upcoming Pilot Program

Mokusei Intelligence has announced that it is actively seeking partners and collaborators, especially from the education and travel sector. ...

Zydus Cadila's net profit up 41 pc in Q3 to Rs 527 crore - Hindi News | Zydus Cadila's net profit up 41 pc in Q3 to Rs 527 crore | Latest business News at Lokmattimes.com

Business :Zydus Cadila's net profit up 41 pc in Q3 to Rs 527 crore

Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the corresponding quarter of previous year. ...

Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154 per cent YoY Finance Cost Reduced by 95.40 per cent YoY - Hindi News | Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154 per cent YoY Finance Cost Reduced by 95.40 per cent YoY | Latest business News at Lokmattimes.com

Business :Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154 per cent YoY Finance Cost Reduced by 95.40 per cent YoY

Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31, 2020 (Q3FY21). ...

Zydus' drug shows promise in treating hypoxia in Covid patients - Hindi News | Zydus' drug shows promise in treating hypoxia in Covid patients | Latest national News at Lokmattimes.com

National :Zydus' drug shows promise in treating hypoxia in Covid patients

Ahmedabad, Jan 25 Ahmedabad-headquartered global pharmaceutical company Zydus Cadila on Monday said it has received positive results from ... ...

At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India - Hindi News | At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India | Latest business News at Lokmattimes.com

Business :At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India

Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market. ...